M-Teriflunomide

30 tablets of 14 mg (blister pack)
– DIN 02523833

  • Canadian Reference Product

    Aubagio®

  • Medicinal Ingredient

    Teriflunomide

  • DIN

    02523833

  • Strength

    14 mg

  • Pack Size

    30 tablets

Information for Patients

Information for Healthcare Professionals

  • Product Monograph

    – Consult PDF
  • Prescriber’s Checklist

    – Consult PDF
  • Targeted questionnaires

    If your patient experiences one of the following side effects related with the administration of M-Teriflunomide, kindly contact our Medical Information Department to receive the targeted questionnaire: hepatic effetct, hyperension, hematological effects, infections, progressive multifocal leukoencephalopathy (PML), interstitial lung disease. Exposure in pregnancy and Infant follow up forms are also available through the medical information department.
  • Pregnancy Active Surveillance Program

    +1-833-651-1661

Assistance